SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Marinus Pharmaceuticals shares are trading higher after the company announced it has received FDA rare pediatric disease designation for Ganaxolone for the treatment of CDKL5 deficiency disorder.

Benzinga · -